Journal of Pathology and Translational Medicine10.4132/jptm.2017.10.17201852114-20The Significance of TROP2 Expression in Predicting BRAF Mutations in Papillary Thyroid CarcinomaJoon Seog Kong, Hyeon Jin Kim, Min-Jung Kim, Areumnuri Kim, Dalnim Lee, Kanghee Han, Sunhoo Park, Jae Soo Koh, Jae Kyung Myung,,
Nature Clinical Practice Endocrinology & Metabolism10.1038/ncpendmet0161200624180-181Significance of BRAF mutations in papillary thyroid carcinoma: prognostic and therapeutic implicationsLionel Groussin, James A Fagin,,
Yearbook of Endocrinology10.1016/s0084-3741(09)79273-x20092009143-144High Rate of BRAF and RET/PTC Dual Mutations Associated with Recurrent Papillary Thyroid CarcinomaM. Schott,
Yearbook of Surgery10.1016/s0090-3671(08)70420-820062006157Type and Prevalence of BRAF Mutations Are Closely Associated With Papillary Thyroid Carcinoma Histotype and Patients' Age But Not With Tumour AggressivenessT.J. Fahey,
Scientific Reports10.1038/s41598-017-04948-3201771 BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node MetastasesNajla Fakhruddin, Mark Jabbour, Michael Novy, Hani Tamim, Hisham Bahmad, Fadi Farhat, Ghazi Zaatari, Tarek Aridi, Gernot Kriegshauser, Christian Oberkanins, Rami Mahfouz,,
Yearbook of Surgery10.1016/s0090-3671(10)79723-820102010165-166Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutationT.J. Fahey,
APMIS10.1111/j.1600-0463.2011.02844.x20111205380-386BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patientsHANNA PELTTARI, CAMILLA SCHALIN-JÄNTTI, JOHANNA AROLA, ELIISA LÖYTTYNIEMI, SAKARI KNUUTILA, MATTI J. VÄLIMÄKI
The Laryngoscope10.1002/lary.2466820141249E389-E393BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinomaDaniel J. Givens, Luke O. Buchmann, Archana M. Agarwal, Johannes F. Grimmer, Jason P. Hunt
Endocrinology and Metabolism10.3803/enm.2014.29.4.5362014294536Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic SignificanceMin Jung Jung, Su Kyoung Kwon
BMC Cancer10.1186/1471-2407-14-3832014141Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinomaYanhong Huang, Wenwu Dong, Jing Li, Hao Zhang, Zhongyan Shan, Weiping Teng,,